Morbidity and cause‐specific mortality in first‐time myocardial infarction with nonobstructive coronary arteries
- 25 November 2018
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 285 (4) , 419-428
Abstract
Background: Myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) is receiving increasing interest as a prognostically adverse entity distinct from myocardial infarction with significant coronary artery disease (MI‐CAD). However, data are still limited regarding long‐term cardiovascular morbidity and cause‐specific mortality in MINOCA.Methods: This is a registry‐based cohort study using data from patients admitted to Swedish coronary care units. We investigated various nonfatal outcomes (recurrent MI, hospitalization for heart failure or stroke) and fatal outcomes (cardiovascular, respiratory or cancer‐related mortality) in 4069 patients without apparent acute cardiovascular disease, used as non‐MI controls, 7266 patients with first‐time MINOCA and 69 267 patients with first‐time MI‐CAD.Results: Almost all event rates (median follow‐up 3.8 years) increased in a stepwise fashion across the three cohorts [rates of major adverse events (MAE; composite of all‐cause mortality, recurrent MI, hospitalization for heart failure or stroke): n = 268 (6.6%), n = 1563 (21.5%), n = 17 777 (25.7%), respectively]. Compared to non‐MI controls, MINOCA patients had an adjusted hazard ratio (HR) of 2.12 (95% confidence interval 1.84–2.43) regarding MAE. MINOCA patients had a substantial risk of cardiovascular mortality and the highest numerical risks of respiratory and cancer‐related mortality. Male sex, previous heart failure and chronic obstructive pulmonary disease had a stronger prognostic impact in MINOCA than in MI‐CAD. Female MINOCA patients with atrial fibrillation were at particular risk.Conclusions: Patients with first‐time MINOCA have a considerable risk of adverse events. This stresses the need for a comprehensive search of the cause of MINOCA, thorough treatment of underlying disease triggers and close follow‐up.Keywords
Funding Information
- Swedish Foundation of Strategic Research
This publication has 19 references indexed in Scilit:
- Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery DiseaseCirculation, 2017
- Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary ArteriesThe American Journal of Cardiology, 2015
- Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary ArteriesCirculation, 2015
- Prognosis of Patients With Non–ST-Segment–Elevation Myocardial Infarction and Nonobstructive Coronary Artery DiseaseCirculation: Cardiovascular Interventions, 2014
- Long-Term Prognosis of Patients Presenting With ST-Segment Elevation Myocardial Infarction With No Significant Coronary Artery Disease (from The HORIZONS-AMI Trial)The American Journal of Cardiology, 2013
- Coagulation and cancer: biological and clinical aspectsJournal of Thrombosis and Haemostasis, 2012
- Myocardial infarction without obstructive coronary artery diseaseCurrent Opinion in Cardiology, 2012
- Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe?International Journal of Cardiology, 2011
- The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)Heart, 2010
- Characterization and outcomes of women and men with non–ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: Results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) Quality Improvement InitiativeAmerican Heart Journal, 2009